D9612 Dental Code: Multiple Therapeutic Injections

What D9612 covers

D9612 reports two or more administrations of different therapeutic medications given parenterally at one dental visit: a steroid for swelling plus an antibiotic for an active infection, or an antiemetic for nausea plus an anti-inflammatory for pain.

D9610 is the single-administration version of the same service and sets out what “therapeutic” excludes. This page focuses on the count, which is where D9612 is most often miscoded.

Parenteral is broader than most billers assume. Carrier policy defines it as any route that bypasses the gastrointestinal tract: intramuscular, intravenous, subcutaneous, submucosal, intraosseous, and intranasal. An intranasal drug counts; a swallowed pill does not.

The distinguishing axis: distinct drugs, counted per visit

D9612 turns on the number of chemically distinct medications given during the appointment. These do not raise the count:

• Repeat doses of one drug. A second push of the same steroid is still one medication.
• Multiple injection sites. One antibiotic infiltrated in three places is one drug.
• Multiple routes for one drug. The same medication given IM and then IV is one medication.

Count the distinct drug names on the medication log for that date. One name means D9610. Two or more means D9612, reported once for the visit whether it was two drugs or four. In the PMS, label the codes by count, such as “therapeutic injection, one drug” and “therapeutic injection, two or more different drugs.” Two entries that both read “therapeutic parenteral drug” get picked by whichever is higher in the list.

Repeat dosing of one drug has no clean answer. CDT publishes no code for a second administration of the same medication, so the options are one unit of D9610 for the visit or an attempt at a second unit. Plans split on this, and many treat the appointment as one administration event regardless of dosing. Verify the plan’s position before assuming quantity two will process.

What D9612 is not

The first exclusion is in the CDT descriptor itself; the other two follow from the code definitions and carrier policy.

It is not sedation. Therapeutic drug administration excludes sedatives, anesthetics, and reversal agents. Sedation has its own time-based codes, including D9239 and D9243 for intravenous moderate sedation and D9222 and D9223 for deep sedation and general anesthesia. Carrier policies also exclude drugs given routinely or as part of a general anesthesia, analgesia, sedation, or premedication protocol. Billing a sedation case as D9612 because more than one agent went through the IV is the most expensive miscode on this line. D9612 on the same date as a sedation code invites a records request, and the anesthesia record will show which agents were given and why. Flag that combination in the PMS for review before the claim goes out.

It is not local anesthesia. Numbing the patient is D9210 or D9215, depending on whether a procedure was done that day, and D9215 is bundled into the procedure fee almost every time. A long-acting agent infiltrated for post-surgical pain control is D9613, reported per quadrant. At least one national carrier considers sustained-release infiltration not indicated on current evidence and denies it as a matter of policy.

It is not medication sent home. D9630 reports drugs or medicaments dispensed in the office for home use. A course of oral antibiotics and a fluoride rinse handed to the patient is two products, but it is D9630, because nothing was administered chairside.

Why the claim gets denied

Denials on D9612 fall into four patterns, and only the first is about the count:

1. The chart shows one drug. The claim says two or more medications, the medication log names one, and the line reverses on review. This is the most common audit finding.
2. The plan carries no benefit. Some plans exclude therapeutic drug administration outright. Fee schedules listing D9610 through D9630 as non-covered are common enough to check before the visit.
3. The plan bundles it into the same-day procedure. If the drugs supported a surgical extraction, some plans consider the administration part of that procedure’s fee.
4. The clinical reason is missing. Carrier criteria generally require an unusual circumstance or an existing infection or inflammation, and exclude administration to prevent an infection that has not appeared. “Antibiotic given post-op” without a diagnosis reads as prophylaxis, which several policies exclude by name.

Coverage for therapeutic drug administration varies between plans more than almost anything else in the adjunctive category, so verify the specific plan rather than working from what the last plan did. Record in the patient’s insurance notes whether the plan covers the category, bundles it into same-day surgery, or excludes it, so the front desk does not quote a number that will not hold.

Documentation that supports the claim

An audit of D9612 goes to the medication log first, because it is the only record that proves the count. For each administration, capture:

• The drug, by name. “Steroid and antibiotic given” does not establish distinct drugs.
• The dose, with units.
• The route: intramuscular, intravenous, subcutaneous, submucosal, intraosseous, or intranasal.
• The site of the injection.
• The time it was given.

Two complete entries naming two different drugs document D9612. One entry, or two naming the same drug, will not survive review. Attach the log to the D9612 line, not just the chart, because the clearinghouse sends only what is attached. Practices that keep the log in a clinical note the biller never exports end up appealing without their evidence.

Add the clinical reason: the condition being treated (the infection, the swelling, the nausea) and the circumstance that made the drugs necessary at that appointment. Keep it specific to the patient. A narrative reused verbatim across claims is easy to spot in a batch and weakens the medical-necessity argument on all of them. For how these lines sit alongside the rest of a surgical claim, see the ADA dental claim form guide.